12356 J. Am. Chem. Soc., Vol. 118, No. 49, 1996
Fu¨rstner and Shi
1-(2-Thienyl)-1-octanol (7). Colorless syrup. 1H NMR: δ 0.90
(t, 3H), 1.29 (m, 10H), 1.86 (m, 2H), 2.04 (b, 1H), 4.92 (t, 1H), 6.98
(m, 3H), 7.24 (m, 2H). 13C NMR: δ 13.7, 22.3, 25.4, 28.8, 29.0, 31.4,
39.0, 69.7, 123.3, 124.1, 126.2, 148.7. IR: 3377, 2955, 2927, 1465,
1415, 1378, 1231, 1039, 853, 830, 697. MS: m/z (relative intensity)
212 (10, [M+]), 113 (100), 85 (22).
[4-(Ethoxycarbonyl)phenyl]phenylmethanol (8). Colorless syrup.
1H NMR: δ 1.36 (t, 3H), 2.65 (b, 1H), 4.33 (q, 2H), 5.84 (s, 1H), 7.31
(m, 5H), 7.43 (d, 2H), 7.99 (d, 2H). 13C NMR: δ 14.0, 60.6, 75.5,
125.9, 126.3, 127.5, 128.3, 129.4, 143.0, 148.3, 166.1. IR: 3461,
3062, 3030. 2982, 1716, 1700, 1611, 1453, 1413, 1368, 1279, 1176,
1106, 1019, 873, 755, 701. MS: m/z (relative intensity) 256 (16, [M+]),
211 (14), 183 (13), 177 (30), 165 (11), 151 (100), 123 (32), 105 (63),
77 (27).
mL), and the mixture was stirred for another 3 h to ensure complete
desilylation of the crude silyl ether. A standard extractive workup with
ethyl acetate followed by flash chromatography with hexane/ethyl
acetate (30/1) afforded the title homoallyl alcohol as a colorless syrup
(320 mg, 79%). The isomeric ratio of the crude product is threo:erythro
) 94:6 (GC).1d,35 Threo-isomer. 1H NMR: δ 7.22-7.36 (m, 5H),
5.81 (ddd, 1H, J ) 7.9, 9, 17), 5.22 (dd, 1H, J ) 1, 17), 5.16 (dd, 1H,
J ) 2, 9), 4.35 (d, 1H, J ) 7.9), 2.53 (m, 1H), 2.19 (s, 1H, OH), 0.85
(d, 3H, J ) 6.7). 13C NMR: δ 142.5, 140.7, 128.2, 127.6, 126.5, 116.7,
77.9, 46.2, 16.5. IR: 3425, 3065, 3030, 2975, 2931, 2872, 1639, 1604,
1494, 1454, 1417, 1372, 1197, 1021, 915, 761, 701. MS: m/z (relative
intensity) 162 (0.1, [M+]), 107 (100), 79 (58), 77 (25). Diagnostic
data of the erythro-isomer. 1H NMR: δ 4.57 (d, J ) 5.4), 0.99 (d, J
) 6.9). 13C NMR: δ 44.7, 14.0.
7-Methylenepentadecan-8-ol (9). Colorless syrup. 1H NMR: δ
0.88 (m, 3H), 1.29-1.55 (m, 23H), 2.00 (m, 2H), 4.05 (t, 1H), 4.83
(d, 1H), 5.00 (d, 1H). 13C NMR: δ 13.7, 22.3, 25.4, 27.7, 28.9, 29.2,
31.0, 31.4, 31.5, 35.2, 75.2, 108.7, 152.0. IR: 3354, 2956, 2927, 2857,
1646, 1466, 1378, 1122, 1047, 1020, 900, 724. MS: m/z (relative
intensity) 240 (3, [M+]), 169 (12), 155 (18), 141 (29), 127 (26), 123
(20), 95 (17), 81 (35) 71 (100).
2-Methylene-1-phenyl-1-octanol (10). Colorless syrup. 1H
NMR: δ 0.85 (t, 3H), 1.18-1.51 (m, 8H), 1.75-2.08 (m, 3H), 4.98
(s, 1H), 5.16 (s, 1H), 5.27 (s, 1H); 7.33 (m, 5H). 13C NMR: δ 13.7,
22.2, 27.4, 28.7, 31.3, 31.5, 77.0, 109.3, 126.4, 127.3, 128.0, 141.9,
150.9. IR: 3376, 3029, 2956, 2928, 2858, 1647, 1493, 1454, 1038,
1026, 903, 841, 763, 699. MS: m/z (relative intensity) 218 (38, [M+]),
147 (24), 133 (100), 129 (10), 120 (50), 107 (46), 105 (33), 91 (10),
79 (29), 77 (19), 55 (21).
2-Methylene-1-[3,4-(methylenedioxy)phenyl]-1-hexanol (12). Col-
orless syrup. 1H NMR: δ 0.85 (t, 3H), 1.17-1.46 (m, 4H), 1.65-
2.04 (m, 3H), 4.95 (s, 1H), 5.04 (s, 1H), 5.24 (s, 1H), 5.93 (s, 2H),
6.80 (m, 3H). 13C NMR: δ 13.6, 22.1, 29.6, 31.3, 76.7, 100.6, 106.8,
107.6, 108.9, 120.0, 136.0, 146.7, 147.4, 150.8. IR: 3390, 2957, 2930,
2873, 1650, 1503, 1487, 1442, 1247, 1094, 1041, 951, 933, 809. MS:
m/z (relative intensity) 234 (100, [M+]), 177 (14), 151 (67), 123 (11),
93 (15).
Representative Procedure for the CrCl2-Catalyzed Reaction of
Alkynyl Halides with Aldehydes. 5-Dodecyn-7-ol (17). To a stirred
suspension of CrCl2 (26 mg, 0.21 mmol), NiCl2 (9 mg, 0.7 mmol),
and Mn powder (120 mg, 2.1 mmol) in THF (7 mL) were added
successively hexanal (125 mg, 1.25 mmol) and 1-iodo-1-hexyne (520
mg, 2.5 mmol). After the mixture was stirred for 6 h at ambient
temperature, water (10 mL) was added and the stirring continued for
3 h until the silyl ether was quantitatively cleaved. The mixture was
extracted with ethyl acetate in three portions (30 mL each), the
combined organic layers were washed with brine, dried over Na2SO4,
and evaporated, and the residue was purified by flash chromatography
with hexane/ethyl acetate (10/1) as eluent, affording the title compound
as pale yellow syrup (180 mg, 79%). 1H NMR: δ 4.38 (tt, 1H, J ) 2,
6.4), 2.25 (dt, 2H, J ) 2, 6.8), 1.78 (s, 1H, OH), 1.34-1.75 (m, 12H),
0.95 (t, 3H), 0.94 (t, 3H). 13C NMR: δ 85.1, 81.0, 62.4, 37.8, 31.1,
30.4, 24.5, 22.2, 21.5, 18.0, 13.6, 13.2. IR: 3346, 2957, 2933, 2861,
2232, 1466, 1432, 1379, 1329, 1261, 1148, 1109, 1026, 914. MS: m/z
(relative intensity) 182 (0.2, [M+]), 153 (2), 139 (4), 125 (18), 111
(100), 55 (17).
The following products have been obtained analogously.
1-Undecen-4-ol (2a). Colorless syrup. 1H NMR: δ 0.81 (m, 3H),
1.21 (m, 8H), 1.38 (m, 2H), 2.00-2.34 (m, 3H), 3.63 (m, 1H), 5.05
(m, 1H), 5.13 (m, 1H), 5.69-5.90 (m, 1H). 13C NMR: δ 13.7, 22.3,
25.3, 28.9, 29.2, 31.5, 36.4, 41.5, 70.5, 117.6, 134.5. IR: 3357, 3077,
2957, 2928, 2856, 1641, 1466, 1438, 1378, 1342, 1126, 1074, 1044,
994, 912. MS: m/z (relative intensity) 170 (0.3, [M+]), 129 (24), 111
(22), 69 (100), 55 (36).
2-Methylene-4-(2-phenyl-1-ethyl)butyrolactone (20). Colorless
syrup. 1H NMR: δ 1.82-2.13 (m, 2H), 2.58 and 3.04 (dtAB system,
2H, J ) 2.5, 7.8, 17), 2.76 (m, 2H), 4.52 (m, 1H), 5.62 (t, J ) 2.5,
1H), 6.23 (t, J ) 2.5, 1H), 7.15-7.34 (m, 5H). 13C NMR: δ 31.0,
33.2, 37.7, 76.2, 121.8, 125.9, 128.1, 128.2, 134.3, 140.3, 169.9. IR:
3027, 2932, 2861, 1762, 1665, 1603, 1497, 1454, 1398, 1342, 1278,
1265, 1164, 1128, 1023, 937, 814, 752, 701, 627. MS: m/z (relative
intensity) 202 (18, [M+]), 117 (100), 91 (71).
3-Methyl-1-nonen-4-ol (25). Threo:erythro ) 92:8 (GC).36 Color-
less syrup. Threo-isomer. 1H NMR: δ 5.68-5.85 (m, 1H), 5.04-
5.15 (m, 2H), 3.36-3.44 (m, 1H), 2.22 (virt-hex, 1H), 1.68 (s, 1H,
OH), 1.31-1.49 (m, 10H), 1.03 (d, 3H, J ) 6.9), 0.90 (vt, 3H, J )
6.4). 13C NMR: δ 140.4, 116.0, 74.7, 44.0, 34.2, 31.9, 25.4, 22.6,
16.2, 14.0, 13.7. IR: 3382, 3076, 2959, 2931, 2860, 1639, 1460, 1417,
1378, 1260, 1121, 1096, 1000, 912. MS: m/z (relative intensity) 156
(6, [M+], 101 (43), 99 (24), 83 (100), 56 (88), 55 (74), 43 (18), 41
(22). Diagnostic data for the erythro-isomer. 1H NMR: δ 1.02 (d, J
) 6.9). 13C NMR: δ 140.8, 115.0.
(1S*,2S*)-2,6-Dimethyl-2-ethenyl-1-phenyl-5-hepten-1-ol (29). Col-
orless syrup.8c Isomeric ratio S*,S*:R*,S* ) 94:6 (GC). Major isomer.
1H NMR: δ 7.30-7.40 (m, 5H), 5.92 (dd, 1H, J ) 10.8, 17.5), 5.33
(dd, 1H, J ) 1.5, 10.8), 5.15 (dd, 1H, J ) 1.5, 17.5), 5.05-5.22 (m,
1H), 4.47 (s, 1H), 2.02 (br s, 1H, OH), 1.92 (q, 2H), 1.71 (d, 3H, J )
1), 1.61 (s, 3H), 1.22-1.56 (m, 2H), 0.98 (s, 3H). 13C NMR: δ 143.6,
140.1, 130.9, 127.7, 127.1, 127.0, 124.4, 115.5, 79.7, 45.6, 37.2, 25.3,
22.5, 17.3, 15.9. IR: 3448, 3083, 3030, 2969, 2925, 2857, 1637, 1604,
1493, 1453, 1413, 1375, 1189, 1083, 1048, 1012, 915, 730, 703. MS:
m/z (relative intensity) 244 (0.6, [M+]), 138 (31), 123 (36), 107 (100),
95 (80), 82 (11), 79 (55), 77 (28), 69 (97), 41 (40).
4-Methyl-1-decen-4-ol (22). 1H NMR: δ 5.85 (X part of ABX,
1H), 5.05-5.16 (AB part of ABX, 2H), 2.22 (d, 2H, J ) 7.4), 1.60 (br
s, 1H, OH), 1.28-1.50 (m, 10H), 1.16 (s, 3H), 0.89 (vt, 3H). 13C
NMR: δ 133.8, 118.1, 71.8, 45.9, 41.5, 31.5, 29.5, 26.3, 23.4, 22.2,
13.7. IR: 3395, 3076, 2959, 2932, 2859, 1641, 1465, 1376, 1141,
1103, 1081, 1046, 998, 913. MS: m/z (relative intensity) 152 (5), 129
(49), 95 (13), 85 (21), 69 (61), 55 (27), 43 (100).
1-Phenyl-2-heptyn-1-ol (18). Obtained according to the procedure
outlined above as a pale yellow syrup. 1H NMR: δ 7.24-7.55 (m,
5H), 5.42 (t, 1H, J ) 1), 2.26 (dt, 3H, J ) 1, 6.8), 1.32-1.60 (m, 4H),
0.91 (t, 3H, J ) 7). 13C NMR: δ 141.0, 128.2, 127.8, 126.3, 87.3,
79.6, 64.5, 30.3, 21.6, 18.2, 13.2. IR: 3374, 3064, 3031, 2958,
2933, 2872, 2280, 2227, 1603, 1493, 1454, 1430, 1379, 1328, 1192,
1135, 1002, 758, 726, 698, 635. MS: m/z (relative intensity) 188 (100,
[M+]), 187 (24), 145 (53), 131 (21), 117 (24), 115 (23), 105 (14), 91
(20), 77 (23).
Representative Procedure for CrCl3-Catalyzed Reactions. Meth-
yl 7-Hydroxy-8-methyl-9-decenoate (27). To a stirred suspension of
CrCl3 (27 mg, 0.17 mmol) and Mn (230 mg, 4.2 mmol) in THF (10
mL) were added successively methyl 7-oxoheptanoate (390 mg, 2.5
mmol), (E)-crotyl bromide (675 mg, 5.0 mmol), and TMSCl (0.75 mL,
6.0 mmol) at ambient temperature. Water was added after a reaction
time of 6 h, and the stirring was continued for another 3 h to ensure
Representative Procedure for the CrCl2-Catalyzed Reaction of
Allyl Halides with Aldehydes. 2-Methyl-1-phenyl-3-buten-1-ol (24).
To a stirred suspension of CrCl2 (22 mg, 0.18 mmol) and Mn (230
mg, 4.2 mmol) in THF (10 mL) was added successively benzaldehyde
(265 mg, 2.5 mmol), (E)-crotyl bromide (675 mg, 5.0 mmol), and
TMSCl (0.75 mL, 6.0 mmol). The mixture was stirred for 6 h at
ambient temperature, the reaction was quenched by adding water (10
(35) The stereochemical assignment was made according to the data given
in ref. 1d and in the following references: (a) Fujita, K.; Schlosser, M.
HelV. Chim. Acta 1982, 65, 1258-1263. (b) Gambaro, Marton, D.; Peruzzo,
V.; Tagliavini, G. J. Organomet. Chem. 1982, 226, 149-155.
(36) Stereochemical assignment by comparison with the data reported
in the following: Furlani, D.; Marton, D. J. Chromatogr. 1986, 369, 313-
320.